Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Bladder Cancer

Free Subscription 27.02.2023 1 Acta Anaesthesiol Scand 1 Acta Clin Croat 1 Appl Immunohistochem Mol Morphol 1 Arab J Urol 2 BJUI Compass 2 BMC Urol 1 Br J Cancer 1 Cell Death Dis 1 Commun Biol 1 Curr Oncol 1 Eur Urol 1 Eur Urol Oncol 2 Front Immunol 1 Front Oncol 1 Gene 1 Indian J Urol 1 Infect Agent Cancer 1 Int Urol Nephrol 1 J Cancer Res Clin Oncol 1 J Transl Med 1 Lab Invest 1 Mar Drugs 2 Medicine (Baltimore) 1 Minerva Urol Nephrol 1 Mol Cancer Ther 1 Oncol Lett 1 Pathologie (Heidelb) 1 Quant Imaging Med Surg 1 Strahlenther Onkol 1 Toxicol Sci 1 Tumour Biol 1 Urol Int 1 Urol Oncol 1 World J Urol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Anaesthesiol Scand

1. KORGVEE A, Veskimae E, Huhtala H, Koskinen H, et al
   Posterior quadratus lumborum block versus epidural analgesia for postoperative pain management after open radical cystectomy: a randomized clinical trial.
   Acta Anaesthesiol Scand. 2022 Dec 22. doi: 10.1111/aas.14188.
   PubMed         Abstract available
   
   

   
   Acta Clin Croat

2. MATIC M, Dmitrovic B, Matic S, Kurbel S, et al
   URINARY BLADDER CANCER RECURRENCE AND EXPRESSION OF LYNCH AND HER MARKERS: SEARCHING FOR IMMUNOHISTOCHEMICAL PATTERNS AMONG 113 TUMORS FROM 33 PATIENTS.
   Acta Clin Croat. 2022;61:239-247.
   PubMed         Abstract available
   
   

   
   Appl Immunohistochem Mol Morphol

3. JHAN JH, Ke HL, Liang PI, Hsu WC, et al
   High MRE11 Expression Level Predicts Poor Survival in Upper Tract Urothelial Carcinomas.
   Appl Immunohistochem Mol Morphol. 2023;31:94-100.
   PubMed         Abstract available
   
   

   
   Arab J Urol

4. AWADA H, Ali AH, Zeineddine MA, Nassereldine H, et al
   The status of bladder cancer research worldwide, a bibliometric review and recommendations.
   Arab J Urol. 2022;21:1-9.
   PubMed         Abstract available
   
   

   
   BJUI Compass

5. GOTSCHALL JW, Major CK, Jacobs LA, Blauch A, et al
   Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study.
   BJUI Compass. 2022;4:164-166.
   PubMed        
   
   
6. MIAN A, Wei J, Shi Z, Rifkin AS, et al
   Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort.
   BJUI Compass. 2022;4:156-163.
   PubMed         Abstract available
   
   

   
   BMC Urol

7. CHENG TH, Lu ZH, Hsu CW
   Gross hematuria as the presentation of ureteral paraganglioma: a case report and literature review.
   BMC Urol. 2023;23:21.
   PubMed         Abstract available
   
   
8. LI S, Zhang J, Tian Y, Zhu Y, et al
   De novo upper tract urothelial carcinoma after renal transplantation: a single-center experience in China.
   BMC Urol. 2023;23:23.
   PubMed         Abstract available
   
   

   
   Br J Cancer

9. TSAI YC, Wang TY, Hsu CL, Lin WC, et al
   Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling.
   Br J Cancer. 2023 Feb 21. doi: 10.1038/s41416-023-02195.
   PubMed         Abstract available
   
   

   
   Cell Death Dis

10. WANG N, Chen RX, Deng MH, Wei WS, et al
    m(5)C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization.
    Cell Death Dis. 2023;14:139.
    PubMed         Abstract available
    
    

    
    Commun Biol

11. GUNERI-SOZERI PY, Ozden-Yilmaz G, Kisim A, Cakiroglu E, et al
    FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer.
    Commun Biol. 2023;6:199.
    PubMed         Abstract available
    
    

    
    Curr Oncol

12. SEISEN T, Labban M, Lipsitz SR, Preston MA, et al
    Assessment of the Ecological Association between Tobacco Smoking Exposure and Bladder Cancer Incidence over the Past Half-Century in the United States.
    Curr Oncol. 2023;30:1986-1998.
    PubMed         Abstract available
    
    

    
    Eur Urol

13. DE ANGELIS M, Briganti A, Montorsi F, Moschini M, et al
    Re: A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2023 Feb 16:S0302-2838(23)02571-X. doi: 10.1016/j.eururo.2023.
    PubMed        
    
    

    
    Eur Urol Oncol

14. INMAN BA, Hahn NM, Stratton K, Kopp R, et al
    A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guerin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2023 Feb 15:S2588-9311(23)00032.
    PubMed         Abstract available
    
    

    
    Front Immunol

15. BENITEZ R, Yu K, Sirota M, Malats N, et al
    Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer.
    Front Immunol. 2023;14:986598.
    PubMed         Abstract available
    
    
16. ZHOU TL, Chen HX, Wang YZ, Wen SJ, et al
    Single-cell RNA sequencing reveals the immune microenvironment and signaling networks in cystitis glandularis.
    Front Immunol. 2023;14:1083598.
    PubMed         Abstract available
    
    

    
    Front Oncol

17. SHAH SD, Gillard BM, Wrobel MM, Karasik E, et al
    Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer.
    Front Oncol. 2023;13:1120329.
    PubMed         Abstract available
    
    

    
    Gene

18. FU S, Luan T, Jiang C, Huang Y, et al
    Corrigendum to "miR-3622a promotes proliferation and invasion of bladder cancer cells by downregulating LASS2" [Gene 701 (2019) 23-31].
    Gene. 2023;862:147266.
    PubMed        
    
    

    
    Indian J Urol

19. BHARGAVA P
    Adjuvant intravesical chemohyperthermia or conventional chemotherapy in an era of bacillus Calmette-Guerin shortage for non-muscle invasive bladder cancer: The HIVEC-II trial.
    Indian J Urol. 2023;39:75-76.
    PubMed        
    
    

    
    Infect Agent Cancer

20. YOHANA C, Bakuza JS, Kinung'hi SM, Nyundo BA, et al
    The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: a retrospective review over 10 years period.
    Infect Agent Cancer. 2023;18:10.
    PubMed         Abstract available
    
    

    
    Int Urol Nephrol

21. CANO GARCIA C, Piccinelli ML, Tappero S, Panunzio A, et al
    Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities.
    Int Urol Nephrol. 2023 Feb 23. doi: 10.1007/s11255-023-03517.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

22. SONG Y, Qin C, Zhang C, Peng Y, et al
    GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females.
    J Cancer Res Clin Oncol. 2023 Feb 19. doi: 10.1007/s00432-023-04640.
    PubMed         Abstract available
    
    

    
    J Transl Med

23. SEOK J, Kwak HJ, Kwak Y, Lee M, et al
    Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer.
    J Transl Med. 2023;21:129.
    PubMed         Abstract available
    
    

    
    Lab Invest

24. LI X, Xiong W, Wang Y, Li Y, et al
    p53 Activates the Lipoxygenase Activity of ALOX15B via Inhibiting SLC7A11 to Induce Ferroptosis in Bladder Cancer Cells.
    Lab Invest. 2023;103:100058.
    PubMed         Abstract available
    
    

    
    Mar Drugs

25. CHANG CH, Lin BJ, Chen CH, Nguyen NL, et al
    Stellettin B Induces Cell Death in Bladder Cancer Via Activating the Autophagy/DAPK2/Apoptosis Signaling Cascade.
    Mar Drugs. 2023;21:73.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

26. ZHANG L, Liu B, Su J
    CCNB2 as a potential biomarker of bladder cancer via the high throughput technology.
    Medicine (Baltimore). 2023;102:e32825.
    PubMed         Abstract available
    
    
27. WU Z, Zeng J, Wu M, Liang Q, et al
    Identification and validation of the pyroptosis-related long noncoding rna signature to predict the prognosis of patients with bladder cancer.
    Medicine (Baltimore). 2023;102:e33075.
    PubMed         Abstract available
    
    

    
    Minerva Urol Nephrol

28. SARKIS J, Diamand R, Aoun F, Assenmacher G, et al
    Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registry.
    Minerva Urol Nephrol. 2023;75:50-58.
    PubMed         Abstract available
    
    

    
    Mol Cancer Ther

29. MARQUES M, Corral S, Sanchez-Diaz M, Del Pozo N, et al
    Tumor and stromal cell targeting with Nintedanib and Alpelisib overcomes intrinsic bladder cancer resistance.
    Mol Cancer Ther. 2023 Feb 20:MCT-21-0667. doi: 10.1158/1535-7163.MCT-21-0667.
    PubMed         Abstract available
    
    

    
    Oncol Lett

30. LIU S, Yao Y, Wang ZK, Sun LJ, et al
    Prognostic value of the sarcomatoid component in bladder cancer: A propensity score matching study.
    Oncol Lett. 2023;25:103.
    PubMed         Abstract available
    
    

    
    Pathologie (Heidelb)

31. GAISA NT, Hartmann A, Knuchel-Clarke R
    [New WHO classification 2022: urinary bladder cancer].
    Pathologie (Heidelb). 2023 Feb 24. doi: 10.1007/s00292-023-01183.
    PubMed         Abstract available
    
    

    
    Quant Imaging Med Surg

32. WU P, Wu K, Li Z, Liu H, et al
    Multimodal investigation of bladder cancer data based on computed tomography, whole slide imaging, and transcriptomics.
    Quant Imaging Med Surg. 2023;13:1023-1035.
    PubMed         Abstract available
    
    

    
    Strahlenther Onkol

33. GRABENBAUER F, Flentje M
    [Organ-preserving treatment of muscle-invasive bladder cancer: 10-year data of the British BC2001 study].
    Strahlenther Onkol. 2023 Feb 23. doi: 10.1007/s00066-023-02052.
    PubMed        
    
    

    
    Toxicol Sci

34. GUFFROY M, Trela B, Kambara T, Stawski L, et al
    Selective inhibition of integrin alphavbeta6 leads to rapid induction of urinary bladder tumors in cynomolgus macaques.
    Toxicol Sci. 2023;191:400-413.
    PubMed         Abstract available
    
    

    
    Tumour Biol

35. ALSHEHRI E, Al-Dogmi AM, Al-Hazani TMI, Alwaili MA, et al
    Patterns of mutations in nine cancer-related genes and PAF development among smoking male patients diagnosed with bladder cancer.
    Tumour Biol. 2023;45:1-14.
    PubMed         Abstract available
    
    

    
    Urol Int

36. BOLAT D, Baltaci S, Akgul M, Karabay E, et al
    Predictive Role of the Systemic Immune Inflammation Index for Intravesical BCG Response in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2023 Feb 21:1-7. doi: 10.1159/000528740.
    PubMed         Abstract available
    
    

    
    Urol Oncol

37. KOSITZA J, Nguyen J, Hong T, Mantwill K, et al
    Identification of the KIF and MCM protein families as novel targets for combination therapy with CDK4/6 inhibitors in bladder cancer.
    Urol Oncol. 2023 Feb 20:S1078-1439(23)00010.
    PubMed         Abstract available
    
    

    
    World J Urol

38. PIGNOT G, Baboudjian M, Lebacle C, Chamouni A, et al
    Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure.
    World J Urol. 2023 Feb 22. doi: 10.1007/s00345-023-04332.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: